Scientists have found that a test to detect circulating tumor DNA can predict lung cancer outcome. Scientists from the Francis Crick Institute, UCL, UCLH and Personalis have found that a test to ...

A combination of two existing chemotherapy drugs has been used to fight bladder cancer successfully for the first time in Singapore. This new union of the two “off-label” drugs – gemcitabine and ...

Researchers from the University of Sheffield and Barts Cancer Institute at Queen Mary, University of London have found that ...

ImmunityBio is at the forefront of developing innovative immunotherapies and cell therapies. The company has a vertically integrated approach, allowing it to oversee every step of development, from ...

They were used on five patients, and four of them are now either in remission or cancer-free. Read more at straitstimes.com.

J&J acquired rights to TAR-200 when it bought privately-owned biotech Taris for an undisclosed sum in 2019, and has big sales ...

A Keighley deli owner is taking part in clinical trials of a new drug which could transform bladder cancer treatment.

A new artificial intelligence-powered tool called MISO (Multi-modal Spatial Omics) can detect cell-level characteristics of cancer by looking at data from extremely small pieces of tissue-some as ...

A KEIGHLEY deli owner is taking part in clinical trials of a new drug which could transform bladder cancer treatment.

Dual blocking SHP2 and FGFR2 can not only promote the targeted tumor-killing effects and overcome FGFR2 inhibitor resistance caused by feedback activation, but also activate T cell-mediated anti-tumor ...

ImmunityBio, Inc. (NASDAQ: IBRX), a leading immunotherapy company, today announced significant progress in its ongoing ...